Application 209010
- Type
- ANDA
- Sponsor
- SCIEGEN PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 5MG BASE;20MG | No | No |
| 002 | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 5MG BASE;40MG | No | No |
| 003 | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 10MG BASE;20MG | No | No |
| 004 | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | TABLET;ORAL | EQ 10MG BASE;40MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50228-365 | Amlodipine and Olmesartan Medoxomil | Amlodipine and Olmesartan Medoxomil | ScieGen Pharmaceuticals, Inc | ANDA | Current |
| 50228-366 | Amlodipine and Olmesartan Medoxomil | Amlodipine and Olmesartan Medoxomil | ScieGen Pharmaceuticals, Inc | ANDA | Current |
| 50228-367 | Amlodipine and Olmesartan Medoxomil | Amlodipine and Olmesartan Medoxomil | ScieGen Pharmaceuticals, Inc | ANDA | Current |
| 50228-368 | Amlodipine and Olmesartan Medoxomil | Amlodipine and Olmesartan Medoxomil | ScieGen Pharmaceuticals, Inc | ANDA | Current |